Published in Sci Rep on October 04, 2016
Endotoxin, Neutrophil Function and Albumin in Renal Insufficiency (ENARI) | NCT01362569
Detection of endotoxin in the blood of patients with sepsis due to gran-negative bacteria. N Engl J Med (1970) 3.55
The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology (2010) 3.43
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int (2000) 2.80
Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol (2010) 2.69
Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol (1987) 2.28
Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int (1999) 2.21
Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol (1998) 1.97
Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant (2006) 1.90
Inflammation in end-stage renal disease--what have we learned in 10 years? Semin Dial (2010) 1.82
Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol (2004) 1.70
Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am J Kidney Dis (2009) 1.54
Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis. Scand J Gastroenterol (1976) 1.54
Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis. Am J Kidney Dis (2009) 1.52
Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial (2006) 1.44
Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol (2005) 1.29
Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol (2006) 1.26
Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. J Pediatr Gastroenterol Nutr (1995) 1.25
Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. Gut (1991) 1.19
Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int (2010) 1.16
Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int (2006) 1.15
Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron (1993) 1.07
Intestinal and hemodynamic impairment following mesenteric ischemia/reperfusion. J Surg Res (2001) 1.07
Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab (1996) 1.06
Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res (2009) 1.05
Simultaneous determination of myocardial nucleotides, nucleosides, purine bases and creatine phosphate by ion-pair high-performance liquid chromatography. J Chromatogr (1992) 1.04
Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: effects of low- and high-protein diets. Nephron (1990) 1.03
Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant (2006) 1.01
Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol (2009) 1.01
S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation (2002) 1.01
Aging affects high-density lipoprotein composition and function. Biochim Biophys Acta (2013) 0.98
Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant (2005) 0.98
Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci (1998) 0.97
Innate immune dysfunction in acute and chronic liver disease. Wien Klin Wochenschr (2009) 0.96
Importance of oxidatively modified proteins in chronic renal failure. Kidney Int Suppl (2001) 0.96
Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant (2015) 0.94
Early gut barrier dysfunction in patients with severe acute pancreatitis: attenuated by continuous blood purification treatment. Int J Artif Organs (2010) 0.94
Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol (2008) 0.93
The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst. Biochem Biophys Res Commun (2005) 0.90
Underlying disorders and their impact on the host response to infection. Clin Infect Dis (2005) 0.89
Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int (2004) 0.88
Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res (2005) 0.87
Why do young people with chronic kidney disease die early? World J Nephrol (2014) 0.87
Reappraisal with meta-analysis of bacteremia, endotoxemia, and mortality in gram-negative sepsis. J Clin Microbiol (1995) 0.87
Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol (2014) 0.87
The preliminary experimental and clinical study of the relationship between the pigment gallstone and intestinal mucosal barrier. J Gastroenterol Hepatol (2009) 0.85
Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol (1996) 0.85
Hydrogen peroxide generation by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent. Clin Diagn Lab Immunol (1996) 0.83
Endotoxemia in end-stage kidney disease. Semin Dial (2014) 0.82
Polymorphonuclear leukocyte injury by methylglyoxal and hydrogen peroxide: a possible pathological role for enhanced oxidative stress in chronic kidney disease. Nephrol Dial Transplant (2008) 0.81
NADH supplementation decreases pinacidil-primed I K ATP in ventricular cardiomyocytes by increasing intracellular ATP. Br J Pharmacol (2003) 0.81
Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol (1995) 0.80
Effect of diabetic retinopathy on redox state of aqueous humor and serum albumin in patients with senile cataract. Tokai J Exp Clin Med (2001) 0.79
Novel C5-dependent mechanism of neutrophil stimulation by bioincompatible dialyzer membranes. J Am Soc Nephrol (1999) 0.79
Intestinal mucosal permeability of children with cefaclor-associated serum sickness-like reactions. Eur J Pediatr (2013) 0.79
Endotoxin measures in patients' sample: how valid are the results? J Hepatol (2007) 0.79
Biocompatibility of cellulosic and synthetic membranes assessed by leukocyte activation. Am J Nephrol (2004) 0.79
Reduced intestinal permeability measured by differently sized polyethylene glycols in acute uremic rats. Nephron (1992) 0.78
Urinary excretion of differently sized polyethylene glycols after intravenous administration in uremic and control rats: effects of low- and high-protein diets. Nephron (1990) 0.78
Biomarkers for assessing mucosal barrier dysfunction induced by chemotherapy: Identifying a rapid and simple biomarker. Clin Lab (2015) 0.78
Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate. Anticancer Agents Med Chem (2016) 0.77
How common is early chronic kidney disease? A background paper prepared for the UK Consensus Conference on early chronic kidney disease. Nephrol Dial Transplant (2007) 0.77
Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment Pharmacol Ther (2016) 0.76
The uraemic toxin phenylacetic acid contributes to inflammation by priming polymorphonuclear leucocytes. Nephrol Dial Transplant (2012) 0.76
Contributing factors to the inhibition of phagocytosis in hemodialyzed patients. Kidney Int (1993) 0.76
Impaired gut barrier in experimental chronic uremic rats. Miner Electrolyte Metab (1992) 0.76
Association of plasma diamine oxidase and intestinal fatty acid-binding protein with severity of disease in patient with heat stroke. Am J Emerg Med (2015) 0.76
CD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil Dysfunction. PLoS One (2015) 0.76
Increased Hepato-Splanchnic Vasoconstriction in Diabetics during Regular Hemodialysis. PLoS One (2015) 0.76
The urea decomposition product cyanate promotes endothelial dysfunction. Kidney Int (2014) 2.81
Knowledge and attitude of ICU nurses, students and patients towards the Austrian organ donation law. BMC Med Ethics (2013) 1.57
High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration. PLoS One (2016) 1.39
Anti-psoriatic therapy recovers high-density lipoprotein composition and function. J Invest Dermatol (2013) 0.96
Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function. Exp Dermatol (2014) 0.82
Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes. PLoS One (2016) 0.80
Extracorporeal liver support devices for listed patients. Liver Transpl (2016) 0.79
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect. PLoS One (2016) 0.78
Effects of zeolite supplementation on parameters of intestinal barrier integrity, inflammation, redoxbiology and performance in aerobically trained subjects. J Int Soc Sports Nutr (2015) 0.78
Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease. J Crohns Colitis (2016) 0.77
Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients. PLoS One (2016) 0.77
Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung. J Allergy Clin Immunol (2016) 0.77
Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients. Sci Rep (2017) 0.76
Increased Hepato-Splanchnic Vasoconstriction in Diabetics during Regular Hemodialysis. PLoS One (2015) 0.76
The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions. Pharmacology (2015) 0.76
The authors reply. Kidney Int (2015) 0.75
Heterogeneous susceptibility for uraemic media calcification and concomitant inflammation within the arterial tree. Nephrol Dial Transplant (2015) 0.75
The Role of PGE2 in Alveolar Epithelial and Lung Microvascular Endothelial Crosstalk. Sci Rep (2017) 0.75
Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation. Sci Rep (2017) 0.75
Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients. Semin Dial (2017) 0.75
Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland - the observational TRANSIT Study. Wien Klin Wochenschr (2017) 0.75
Calcification score evaluation in patients listed for renal transplantation. Clin Transplant (2016) 0.75
Serum bile acids in liver cirrhosis promote neutrophil dysfunction. Clin Transl Med (2022) 0.75